USPTO serial 79289346
ATHEBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ATHEBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan Meyer
Susan Meyer GREENSFELDER HEMKER & GALE PC200 W MADISON STREETSuite 3300 - Attn.: IP TM DocketCHICAGO, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological and biotechnological preparations, particularly polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, particularly polypeptides and proteins, for reagent development or manufacturing for use in industry and science; chemical, biochemical, biological and biotechnological preparations, particularly polypeptides or proteins, for laboratories, diagnostics and analysis for use in industry and science; chemical, and biochemical, biological and biotechnological substances, particularly polypeptides or proteins, for manufacture of pharmaceutical products | ACTIVE | — |
| 005 | Veterinary medicine and pharmaceutical products and substances, particularly polypeptides and proteins, for treatment of oncological, immunological, cardiovascular, opthamological and neurological diseases as well as preparations, particularly polypeptides and proteins, for medical treatments of oncological, immunological, cardiovascular, opthalmological and neurological diseases | ACTIVE | — |
| 042 | Scientific and technological research, particularly in the biochemical, medical research, diagnostic, and pharmaceutical fields; biochemical and pharmaceutical laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Athebio AG
- Other trademarks owned by Athebio AG
- Other trademarks owned by Athebio AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ATHEBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 6, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 6, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 22, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 18, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |